Audit 31137

FY End
2022-06-30
Total Expended
$955,137
Findings
2
Programs
1
Organization: Merrick, Inc. (MN)
Year: 2022 Accepted: 2023-02-14

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
30231 2022-002 Material Weakness - L
606673 2022-002 Material Weakness - L

Programs

ALN Program Spent Major Findings
93.498 Covid-19 - Provider Relief Fund $955,137 Yes 1

Contacts

Name Title Type
JV8ULKAF6JX9 John Wayne Barker Auditee
6517896200 Tom Hodnefield Auditor
No contacts on file

Notes to SEFA

Title: Note 3. Use of Subrecipients Accounting Policies: Note A - Basis of Presentation - The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of Merrick, Inc. under programs of the federal government for the year ended June 30, 2022. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of Merrick, Inc., it is not intended to and does not present the financial position, changes in net assets, or cash flows of Merrick, Inc. Note B - Summary of Significant Accounting Policies - Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The expenditures in the Schedule of Expenditures of Federal Awards are in agreement with the amounts reported in the financial statements and reports submitted to the Department ofHealth and Human Services. Although the grant award for the provider relief funds (assistance listing number 93.498) is reported as revenue in the statement of activities for the year ended June 30, 2021, all expenditures are reported on the current year schedule of expenditures of federal awards for the year ended June 30, 2022. De Minimis Rate Used: N Rate Explanation: Note C - Indirect Costs - Merrick, Inc. did not elect to use the 10% de minimis cost rate as allowed under the Uniform Guidance. Note D - Subrecipients - Merrick, Inc. did not pass any federal funds to subrecipients during 2022.

Finding Details

Finding 2022-002: Reporting ? Internal Controls over Compliance and Instance of Noncompliance / Federal Program: COVID-19 ? Provider Relief Fund, Assistance Listing Number 93.498, U.S. Department of Health and Human Services / Criteria: Under the Provider Relief Fund Program, providers are required to submit reporting to the Health Resources Services Administration (HRSA). Providers claiming lost revenues are required to calculate and report total patient revenues by quarter for calendar years 2019 through 2021, which was used to compute total lost revenues reported. / Condition: We identified two errors in reporting of quarterly patient revenues that was used to support the amount of lost revenue required by the Provider Relief Fund distributions for Period 2. In both cases, amounts reported understated the amount of lost revenue. However, the understated amounts were still sufficient to full cover the amount of Provider Relief Funds received by Merrick, Inc., resulting in no net impact. / Cause: As noted in Financial Statement Finding 2022-001, Merrick, Inc. experienced turnover within its accounting department at the time reporting for the Provider Relief program for Period 2 was due. This situation, coupled with the evolving nature of the specific terms and conditions of the Provider Relief Fund program, is believed to be the primary cause of the condition noted above. / Effect or potential effect: As noted above in the ?Condition? section, there was no net impact. / Questioned costs: None. / Identification as a repeat finding, if applicable: Not applicable. This is not a repeat finding. / Recommendation: We recommend Merrick, Inc. implement control activities over its financial information as described in Financial Statement Finding 2022-001. In the event Merrick, Inc. has future federal reporting requirements, we recommend that Merrick, Inc. implement control activities to ensure precise reviews are performed to validate the accuracy of data reported prior to final submission.
Finding 2022-002: Reporting ? Internal Controls over Compliance and Instance of Noncompliance / Federal Program: COVID-19 ? Provider Relief Fund, Assistance Listing Number 93.498, U.S. Department of Health and Human Services / Criteria: Under the Provider Relief Fund Program, providers are required to submit reporting to the Health Resources Services Administration (HRSA). Providers claiming lost revenues are required to calculate and report total patient revenues by quarter for calendar years 2019 through 2021, which was used to compute total lost revenues reported. / Condition: We identified two errors in reporting of quarterly patient revenues that was used to support the amount of lost revenue required by the Provider Relief Fund distributions for Period 2. In both cases, amounts reported understated the amount of lost revenue. However, the understated amounts were still sufficient to full cover the amount of Provider Relief Funds received by Merrick, Inc., resulting in no net impact. / Cause: As noted in Financial Statement Finding 2022-001, Merrick, Inc. experienced turnover within its accounting department at the time reporting for the Provider Relief program for Period 2 was due. This situation, coupled with the evolving nature of the specific terms and conditions of the Provider Relief Fund program, is believed to be the primary cause of the condition noted above. / Effect or potential effect: As noted above in the ?Condition? section, there was no net impact. / Questioned costs: None. / Identification as a repeat finding, if applicable: Not applicable. This is not a repeat finding. / Recommendation: We recommend Merrick, Inc. implement control activities over its financial information as described in Financial Statement Finding 2022-001. In the event Merrick, Inc. has future federal reporting requirements, we recommend that Merrick, Inc. implement control activities to ensure precise reviews are performed to validate the accuracy of data reported prior to final submission.